Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors

被引：0
|
作者：
Verschraegen, C. [1 ]
Sweeney, C. [2 ]
Chiorean, G. [2 ]
Lee, F. C. [1 ]
Jones, S. [3 ]
Tye, L. [4 ]
Bello, A. [5 ]
Chao, R. [4 ]
Burris, H., III
机构：
[1] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indiana Univ Canc Ctr, Indianapolis, IN USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70513-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
714
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] Sunitinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors: Updated phase I study results
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [23] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [24] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [25] Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study
    Leong, S.
    Eckhardt, S.
    Chan, E.
    Chow, L.
    VerMeulen, W.
    Camidge, D.
    Rothenberg, M.
    Chow Maneval, E.
    Chao, R.
    Lockhart, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII123 - VII123
  • [26] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [27] Pharmacokinetics and safety of sorafenib in combination with capecitabine in advanced solid tumors
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Bendell, Johanna C.
    Greco, F. Anthony
    Yardley, Denise A.
    Woudenberg, Janet
    Lathia, Chetan D.
    Lane, Cassie M.
    Spigel, David R.
    Hainsworth, John D.
    Burns, Howard A., III
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [28] Phase I evaluation of the safety of conatumumab (AMG 655) in combination with ARM 479 in patients (pts) with advanced, refractory solid tumors
    Chawla, S. P.
    Tabernero, J.
    Kindler, H. L.
    Chiorean, E. G.
    LoRusso, P.
    Hsu, M.
    Haddad, V.
    Bach, B. A.
    Baselga, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors
    Cohen, Steven J.
    Engstrom, Paul F.
    Lewis, Nancy L.
    Langer, Corey J.
    McLaughlin, Susan
    Beard, Mary
    Weiner, Louis M.
    Meropol, Neal J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 1 - 5
  • [30] Phase I safety and tolerability of once daily oral afatinib (A) in combination with gemcitabine (G) in patients with advanced solid tumors.
    Zanetta, Sylvie
    Bennouna, Jaafar
    Isambert, Nicolas
    De-Montserrat, Helene
    Squiban, Patrick J.
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345